Iodine-131-aGPC3-Scfv

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameIodine-131-aGPC3-Scfv
Drug Alias Name131I-aGPC3
ClassificationRadiation-emitting products > Nuclides > Iodine > 131IBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)Radiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionGlypican-3 modulators
TargetsGlypican-3
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesWuhan Union Hospital
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Union Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A